Abstract：Objective: To study effect of somatostatin on abdominal infection after abdominal operation and its influence on serum amylase. Methods: 79 abdominal operations who received therapy from March 2013 to February 2018 in our hospital were selected as research objects. According to simple random number table, those patients were divided into the observation group (n=37) and the control group (n=42). The control group was treated with conventional therapy, while the observation group was on the basis of the control group, somatostatin was used. Then the therapeutic effect, disappearance time of clinical symptoms (nausea and vomiting, abdominal distension and abdominal pain, anal exhaust time), hospitalization time, serum AMS, ascites AMS level, incidence of adverse reactions of two groups after treatment were compared. Results: After treatment, the total effective rate of observation group was statistically higher than that in the control group [94.59% (35/37)vs 66.66%(28/42)](P<0.05); The time of disappearance of clinical symptoms and the time of hospitalization were lower than those of the control group [(1.89±0.70)d vs(4.01±1.21)d, (2.90±0.58)d vs(6.27±1.34)d, (3.76±0.82)d vs (5.80±1.35)d,(4.59±1.02)d vs(7.40±2.15)d](P<0.05); The levels of serum AMS and ascites AMS were significantly lower than those in control group [(142.01±19.42)U/L vs(297.46±26.04)U/L,(124.21±18.47)U/L vs(305.98±31.27)U/L](P<0.05); The total incidence of adverse reactions was lower than that of the control group [8.10%(3/37) vs 28.57%(12/42)](P<0.05). Conclusion: Somatostatin is effective in the treatment of abdominal infection after abdominal surgery. It can effectively improve clinical symptoms, promote postoperative recovery, reduce adverse reactions, and reduce serum AMS. It is safe and reliable.
杨志刚. 生长抑素治疗腹部手术后腹腔感染的疗效及对血清AMS的影响[J]. 河北医学, 2019, 25(1): 63-65.
YANG Zhigang. Effect of Somatostatin on Abdominal Infection after Abdominal Surgery and its Influence on Serum AMS. HeBei Med, 2019, 25(1): 63-65.
[1] 赵明利,薛琪,李国新,等.腹腔镜胃癌根治术围手术期使用生长抑素对减轻胰腺损伤的影响[J].中国普通外科杂志,2015,24(10):1372~1376. [2] Yoshioka T, Kondo Y, Fujiwara T.Successful wound treatment using negative pressure wound therapy without primary closure in a patient undergoing highly contaminated abdominal surgery[J].Surg Case Rep,2018,4(1):85. [3] 甘华.生长抑素治疗腹部手术后早期炎性肠梗阻的疗效及其对血清炎症因子水平的影响[J].中国现代医生,2016,54(20):26~28. [4] Orth K.Preventing Surgical Site Infections Related to Abdominal Drains in the Intensive Care Unit[J].Crit Care Nurse,2018,38(4):20~26. [5] 农跃.腹部手术切口感染的原因探讨[J].当代医学,2013,19(6):96~97. [6] 李原,任建安.腹部创伤合并腹腔感染诊治进展[J].中国实用外科杂志,2016,36(2):238~240. [7] 王革非,任建安,黎介寿.腹部创伤并发腹腔感染的治疗进展[J].创伤外科杂志,2017,19(12):888~891. [8] Fei Y, Li J, Tian W.Safety and feasibility of radical surgery for giant desmoid in abdominal wall[J].Zhonghua Wei Chang Wai Ke Za Zhi,2018,21(7):755~760. [9] 李晓峰,吕少诚,万涛,等.胆管癌术后胆瘘患者腹腔感染的诊断治疗分析[J].中华医院感染学杂志,2014,24(13):3290~3292. [10] Bergquist-Beringer S, Cramer E, Potter C, et al. Exploring the Relationship Between Nursing Specialty Certification and Surgical Site Infections[J].Nurs Adm,2018,48(7~8):400~406. [11] 刘延军,窦东伟,薛寅凯,等.229例术后腹腔感染的分析[J].临床急诊杂志,2014,15(09):522~524. [12] Razavi SA, Desai KA, Hart AM, et al. The Impact of Mesh Reinforcement with Components Separation for Abdominal Wall Reconstruction[J].Am Surg,2018,84(6):959~962. [13] 罗莉,张爱华,邹水晶.生长抑素治疗腹部术后早期炎性肠梗阻的临床价值分析[J].现代诊断与治疗,2015,26(1):176~177. [14] 何文涛,胡娜,黄俊,等.生长抑素联合红霉素对腹部损伤术后肠蠕动功能及血清炎症因子水平的影响[J].临床和实验医学杂志,2018,17(11):1178~1180. [15] 张艳艳.老年患者腹部手术后腹腔感染的危险因素分析及干预对策[J].中国现代普通外科进展,2014,17(2):159~161.
2019, Vol. 25 
冀公网安备13080202000677号